Drugs Made In America Acquisition II Corp. Units Cons of 1 Shs + 1/10 RtDrugs Made In America Acquisition II Corp. Units Cons of 1 Shs + 1/10 RtDrugs Made In America Acquisition II Corp. Units Cons of 1 Shs + 1/10 Rt

Drugs Made In America Acquisition II Corp. Units Cons of 1 Shs + 1/10 Rt

No trades
See on Supercharts
Market capitalization
‪511.74 M‬USD
‪−151.72 K‬USD
0.00USD
‪51.20 M‬
Beta (1Y)
−0.06

About Drugs Made In America Acquisition II Corp. Units Cons of 1 Shs + 1/10 Rt


Sector
CEO
Lynn Stockwell
Headquarters
Fort Lauderdale
ISIN
KYG2851K1206
FIGI
BBG01W8VQXL7
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.

Check out other big names from the same industry as DMIIU.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
ARB
Accelerate Arbitrage Fund ETF
Weight
1.81%
Market value
‪496.90 K‬
USD
SPCX
SPAC and New Issue ETF
Weight
2.75%
Market value
‪249.88 K‬
USD

Explore more ETFs